ONUREG Trademark
ONUREG is a USPTO trademark filed by Celgene Corporation. Status: Registered.
Prosecution Summary
**Trademark Summary** The mark **ONUREG** consists of circles and curved lines positioned to the left of the stylized word **ONUREG** and covers pharmaceuticals in International Class 005, specifically cytokine inhibitory drugs, immune system modulators, and preparations for treating blood disease and cancer. It is owned by **Celgene Corporation**, a Delaware corporation based in Summit, New Jersey. The mark is **registered** on the Principal Register with registration number 6609412. **Recent Activity** Filed on August 27, 2020, the application was published for opposition on November 10, 2020, following a Notice of Allowance on January 5, 2021. After a Statement of Use was accepted on November 29, 2021, the mark was registered on January 4, 2022.
Trademark Facts
| Mark | ONUREG |
|---|---|
| Serial Number | 90142491 |
| Registration Number | 6609412 |
| Status | Registered |
| Filing Date | 2020-08-27 |
| Registration Date | 2022-01-04 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Celgene Corporation |
| Attorney of Record | Xiomara Triana |
| Prosecution Events | 20 |
| Latest Event | R.PR on 2022-01-04 |
Goods & Services
Pharmaceutical preparations for human use, namely, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for the treatment of blood disease and cancer